Adverse cognitive effects linked to polychlorinated biphenyls (PCBs) exposure, a type of endocrine-disrupting chemical (EDC), have the potential to be passed down through generations, according to an animal study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Exposure to dioxins can negatively impact thyroid function, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Breast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Not having reliable access to food has a significant relationship with metabolic syndrome, a condition that increases risk for diseases such as diabetes and heart disease, in Latinx females of reproductive age, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Body mass index (BMI) is not a complete measure of metabolic health, and a high proportion of U.S. adults with normal BMI still have obesity, according to research being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Prenatal exposure to chemicals called phthalates, which are used in hundreds of products, may lead to hormonal changes in females that could affect their future fertility, suggests a study in mice being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
A medication called bempedoic acid reduced the risk of cardiac events as well as statins and may offer an alternative to the popular cholesterol-reducing medications, according to industry-supported research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill.
Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, according to a study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. This variability makes the monitors less useful in tracking glucose levels.
Breastfeeding can improve the number of insulin-producing cells in the pancreas and increase insulin sensitivity in mothers, helping to protect them against type 2 diabetes in later years, suggests a mice study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
More pregnant women developed gestational diabetes during the COVID-19 pandemic than in the preceding two years, according to research being presented on Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Many people with type 1 diabetes struggle to exercise safely while keeping their blood sugar levels within a healthy range, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
The number of children diagnosed with type 2 diabetes continued to rise in the year following the beginning of the COVID-19 pandemic, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Early-time restricted feeding, a type of intermittent fasting, improved fluctuations in blood glucose levels and decreased time above range, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Fewer than six hours or more than 10 hours of sleep, and poor quality of sleep are associated with a greater risk for diabetes, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Keeping adolescents with type 1 diabetes in pediatric diabetes care until at least age 17 may increase the chance that they will have a successful transition to adult care, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
People with polycystic ovary syndrome (PCOS) have a 47% increased risk for death at a younger age compared with those without the condition, according to research being presented on Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
There may be hope for full recovery among men who wish to stop using anabolic-androgenic steroids for muscle growth, according to data being presented on Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Women living with polycystic ovary syndrome (PCOS) experience greater body image concerns than individuals without the condition, according to research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to protect access to evidence-based gender-affirming care for transgender and gender-diverse individuals.
The Endocrine Society selected Dalal S. Ali, M.D., as the recipient of its 2023 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and research contributions related to bone disease, calcium and endocrine disorders in pregnancy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right